Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2013-02

AUTHORS

Guofang Hou, Sheng Zhang, Xiaobei Zhang, Pei Wang, Xiaomeng Hao, Jin Zhang

ABSTRACT

The purpose of this study was to investigate the clinical, pathological, and prognostic characteristics of breast cancer patients with diabetes. In total, the study included 1,013 breast cancer patients with diabetes and 4,621 breast cancer patients without diabetes. Patients with diabetes were further divided into the metformin- and nonmetformin-treated subgroups. The percentage of elderly patients (P < 0.001), obese patients (P < 0.001), and menopausal patients (P < 0.001) as well as the percentage of patients with cardio-cerebrovascular complications (P < 0.001), negative PR (P < 0.001) expression, or low Ki67 expression (P = 0.001) tended to be higher in the diabetic group. In addition, these patients had later pathological stages (P < 0.001), more lymph node metastasis (P = 0.014), and a lower percentage of them were on the anthracycline-based chemotherapy regimen (P = 0.003). The diabetic group was further divided into the metformin and nonmetformin-treated subgroups. The pairwise comparison between the metformin-treated subgroup and the control group did not show a significant difference in the pathological stages (P = 0.0079). However, the HER-2 positive rate tended to be lower in the metformin-treated subgroup than in the nonmetformin-treated subgroup (P = 0.002). No significant difference was found in the lymph node status between the nonmetformin-treated subgroup and the control group (P = 0.057), while the nonmetformin-treated subgroup was associated with higher HER-2 positive expression (P = 0.002). The median follow-up time for this study was 68 months (10-120 months). In Kaplan-Meier analysis, The diabetic group predicted worse survival compared with the control group (P < 0.001) with 5-year survival rates of 79 and 82 %, respectively. The breast cancer mortality rates in the metformin-treated subgroup, the nonmetformin-treated subgroup, and the control group were significantly different (long-rank test, P < 0.001), and the 5-year survival rates were 88, 73, and 82 %, respectively. As shown in the multivariate survival analysis using Cox's regression model, compared with the control group, the metformin-treated subgroup was associated with lower mortality risk (HR 0.762; 95 % CI 0.6-0.968; P = 0.026), whereas the nonmetformin-treated subgroup was associated with higher mortality risk (HR 1.708; 95 % CI 1.461-1.997; P < 0.001). In conclusion, the diabetic group is associated with poor prognosis. Compared with the control group, the metformin-treated subgroup is associated with better clinical outcomes, while nonmetformin-treated subgroup with poorer prognosis. The selection of different antidiabetic drugs may impact the prognosis of breast cancer patients with diabetes. More... »

PAGES

807-816

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-012-2404-y

DOI

http://dx.doi.org/10.1007/s10549-012-2404-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1007952018

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23292119


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Staging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hou", 
        "givenName": "Guofang", 
        "id": "sg:person.01140643410.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140643410.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Sheng", 
        "id": "sg:person.01250560002.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250560002.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Xiaobei", 
        "id": "sg:person.0605031045.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605031045.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Pei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hao", 
        "givenName": "Xiaomeng", 
        "id": "sg:person.01207031500.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207031500.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People\u2019s Republic of China", 
            "Key Laboratory of Cancer Prevention and Therapy, Tianjin, People\u2019s Republic of China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Jin", 
        "id": "sg:person.01240745050.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240745050.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2337/dc11-1313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004387520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.numecd.2009.02.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006412637"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007397922"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1535-6108(02)00055-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008635409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2008.824", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010395233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)60679-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010816607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011989210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-011-1612-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015281687", 
          "https://doi.org/10.1007/s10549-011-1612-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-011-0109-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017161682", 
          "https://doi.org/10.1007/s12032-011-0109-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-012-2170-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022720204", 
          "https://doi.org/10.1007/s10549-012-2170-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-012-2170-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022720204", 
          "https://doi.org/10.1007/s10549-012-2170-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1582-4934.2010.01083.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023042313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.39.7505", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024154053"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-07-2310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027138181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc08-2175", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028017606"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1092952", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028575709"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26420", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030440807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603756", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030523104", 
          "https://doi.org/10.1038/sj.bjc.6603756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.breast.2008.02.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032864891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1940-6207.capr-08-0081", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036462269"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)60706-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037126158"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10911-008-9097-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041148032", 
          "https://doi.org/10.1007/s10911-008-9097-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.17.0829", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042903570"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1010679", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044293745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.19.6410", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044475739"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1096-9896(200004)190:5<537::aid-path577>3.0.co;2-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048279462"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cc.8.1.7499", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072299977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cc.9.1.10407", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072300749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078212999", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078311517", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078511031", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3978/j.issn.2072-1439.2012.10.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078655931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3978/j.issn.2072-1439.2012.10.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078655931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3978/j.issn.2223-4292.2011.12.01", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078663857"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-02", 
    "datePublishedReg": "2013-02-01", 
    "description": "The purpose of this study was to investigate the clinical, pathological, and prognostic characteristics of breast cancer patients with diabetes. In total, the study included 1,013 breast cancer patients with diabetes and 4,621 breast cancer patients without diabetes. Patients with diabetes were further divided into the metformin- and nonmetformin-treated subgroups. The percentage of elderly patients (P\u00a0<\u00a00.001), obese patients (P\u00a0<\u00a00.001), and menopausal patients (P\u00a0<\u00a00.001) as well as the percentage of patients with cardio-cerebrovascular complications (P\u00a0<\u00a00.001), negative PR (P\u00a0<\u00a00.001) expression, or low Ki67 expression (P\u00a0=\u00a00.001) tended to be higher in the diabetic group. In addition, these patients had later pathological stages (P\u00a0<\u00a00.001), more lymph node metastasis (P\u00a0=\u00a00.014), and a lower percentage of them were on the anthracycline-based chemotherapy regimen (P\u00a0=\u00a00.003). The diabetic group was further divided into the metformin and nonmetformin-treated subgroups. The pairwise comparison between the metformin-treated subgroup and the control group did not show a significant difference in the pathological stages (P\u00a0=\u00a00.0079). However, the HER-2 positive rate tended to be lower in the metformin-treated subgroup than in the nonmetformin-treated subgroup (P\u00a0=\u00a00.002). No significant difference was found in the lymph node status between the nonmetformin-treated subgroup and the control group (P\u00a0=\u00a00.057), while the nonmetformin-treated subgroup was associated with higher HER-2 positive expression (P\u00a0=\u00a00.002). The median follow-up time for this study was 68\u00a0months (10-120\u00a0months). In Kaplan-Meier analysis, The diabetic group predicted worse survival compared with the control group (P\u00a0<\u00a00.001) with 5-year survival rates of 79 and 82\u00a0%, respectively. The breast cancer mortality rates in the metformin-treated subgroup, the nonmetformin-treated subgroup, and the control group were significantly different (long-rank test, P\u00a0<\u00a00.001), and the 5-year survival rates were 88, 73, and 82\u00a0%, respectively. As shown in the multivariate survival analysis using Cox's regression model, compared with the control group, the metformin-treated subgroup was associated with lower mortality risk (HR 0.762; 95\u00a0% CI 0.6-0.968; P\u00a0=\u00a00.026), whereas the nonmetformin-treated subgroup was associated with higher mortality risk (HR 1.708; 95\u00a0% CI 1.461-1.997; P\u00a0<\u00a00.001). In conclusion, the diabetic group is associated with poor prognosis. Compared with the control group, the metformin-treated subgroup is associated with better clinical outcomes, while nonmetformin-treated subgroup with poorer prognosis. The selection of different antidiabetic drugs may impact the prognosis of breast cancer patients with diabetes.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10549-012-2404-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "137"
      }
    ], 
    "name": "Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes", 
    "pagination": "807-816", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "25e1e1675fa0136907d649057df204ac8116b78c11767d8a5281703e0934f79f"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23292119"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8111104"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10549-012-2404-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1007952018"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10549-012-2404-y", 
      "https://app.dimensions.ai/details/publication/pub.1007952018"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs10549-012-2404-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-012-2404-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-012-2404-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-012-2404-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-012-2404-y'


 

This table displays all metadata directly associated to this object as RDF triples.

259 TRIPLES      21 PREDICATES      75 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-012-2404-y schema:about N022438ac248a41e7ae6dd007429a801f
2 N0d209143d9e1472cab2c85619c9a398f
3 N13f7588521d14dd3adeeaea81c433a3a
4 N2f85136ac46640a69ef936c7bb69c2d7
5 N3dc877203f44419abf09f62c59a64cd6
6 N3f3592b7f66c43d5b151422256f20920
7 N4dcad98baf8c4842a0fc0bfb6e8829fe
8 N62a1259d98084bf495f8fda009822087
9 N6464f2b47ffe448a80a213ba8ce7e2d5
10 Na0ed53a14fa444139ea62f729ff807f7
11 Nac0548961219439a951dd953df158f79
12 Naf809d530576456aa161a35bfc69150d
13 Nb06a664368104841bf116a694c062768
14 Nefc7f27aa25542b69b41675bfea83572
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author Ndd9d1673122e4941a4293075ffa74231
18 schema:citation sg:pub.10.1007/s10549-011-1612-1
19 sg:pub.10.1007/s10549-012-2170-x
20 sg:pub.10.1007/s10911-008-9097-1
21 sg:pub.10.1007/s12032-011-0109-4
22 sg:pub.10.1038/sj.bjc.6603756
23 https://app.dimensions.ai/details/publication/pub.1078212999
24 https://app.dimensions.ai/details/publication/pub.1078311517
25 https://app.dimensions.ai/details/publication/pub.1078511031
26 https://doi.org/10.1001/jama.2008.824
27 https://doi.org/10.1002/(sici)1096-9896(200004)190:5<537::aid-path577>3.0.co;2-w
28 https://doi.org/10.1002/cncr.26420
29 https://doi.org/10.1002/cncr.26439
30 https://doi.org/10.1016/j.breast.2008.02.002
31 https://doi.org/10.1016/j.numecd.2009.02.006
32 https://doi.org/10.1016/s0140-6736(10)60706-4
33 https://doi.org/10.1016/s0140-6736(11)60679-x
34 https://doi.org/10.1016/s1535-6108(02)00055-7
35 https://doi.org/10.1056/nejmoa1010679
36 https://doi.org/10.1093/annonc/mdr534
37 https://doi.org/10.1111/j.1582-4934.2010.01083.x
38 https://doi.org/10.1126/science.1092952
39 https://doi.org/10.1158/0008-5472.can-07-2310
40 https://doi.org/10.1158/1940-6207.capr-08-0081
41 https://doi.org/10.1200/jco.2008.17.0829
42 https://doi.org/10.1200/jco.2009.19.6410
43 https://doi.org/10.1200/jco.2011.39.7505
44 https://doi.org/10.2337/dc08-2175
45 https://doi.org/10.2337/dc11-1313
46 https://doi.org/10.3978/j.issn.2072-1439.2012.10.17
47 https://doi.org/10.3978/j.issn.2223-4292.2011.12.01
48 https://doi.org/10.4161/cc.8.1.7499
49 https://doi.org/10.4161/cc.9.1.10407
50 schema:datePublished 2013-02
51 schema:datePublishedReg 2013-02-01
52 schema:description The purpose of this study was to investigate the clinical, pathological, and prognostic characteristics of breast cancer patients with diabetes. In total, the study included 1,013 breast cancer patients with diabetes and 4,621 breast cancer patients without diabetes. Patients with diabetes were further divided into the metformin- and nonmetformin-treated subgroups. The percentage of elderly patients (P < 0.001), obese patients (P < 0.001), and menopausal patients (P < 0.001) as well as the percentage of patients with cardio-cerebrovascular complications (P < 0.001), negative PR (P < 0.001) expression, or low Ki67 expression (P = 0.001) tended to be higher in the diabetic group. In addition, these patients had later pathological stages (P < 0.001), more lymph node metastasis (P = 0.014), and a lower percentage of them were on the anthracycline-based chemotherapy regimen (P = 0.003). The diabetic group was further divided into the metformin and nonmetformin-treated subgroups. The pairwise comparison between the metformin-treated subgroup and the control group did not show a significant difference in the pathological stages (P = 0.0079). However, the HER-2 positive rate tended to be lower in the metformin-treated subgroup than in the nonmetformin-treated subgroup (P = 0.002). No significant difference was found in the lymph node status between the nonmetformin-treated subgroup and the control group (P = 0.057), while the nonmetformin-treated subgroup was associated with higher HER-2 positive expression (P = 0.002). The median follow-up time for this study was 68 months (10-120 months). In Kaplan-Meier analysis, The diabetic group predicted worse survival compared with the control group (P < 0.001) with 5-year survival rates of 79 and 82 %, respectively. The breast cancer mortality rates in the metformin-treated subgroup, the nonmetformin-treated subgroup, and the control group were significantly different (long-rank test, P < 0.001), and the 5-year survival rates were 88, 73, and 82 %, respectively. As shown in the multivariate survival analysis using Cox's regression model, compared with the control group, the metformin-treated subgroup was associated with lower mortality risk (HR 0.762; 95 % CI 0.6-0.968; P = 0.026), whereas the nonmetformin-treated subgroup was associated with higher mortality risk (HR 1.708; 95 % CI 1.461-1.997; P < 0.001). In conclusion, the diabetic group is associated with poor prognosis. Compared with the control group, the metformin-treated subgroup is associated with better clinical outcomes, while nonmetformin-treated subgroup with poorer prognosis. The selection of different antidiabetic drugs may impact the prognosis of breast cancer patients with diabetes.
53 schema:genre research_article
54 schema:inLanguage en
55 schema:isAccessibleForFree false
56 schema:isPartOf N3e783fce4d86412bb263cbc0a5937d3e
57 N90189190e0ea49d5a0281bcbd25d8803
58 sg:journal.1092777
59 schema:name Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
60 schema:pagination 807-816
61 schema:productId N0a30286f30654c79be43aa9fe1f1a822
62 N3e4fd855d3394a63983c409e686b4656
63 N46dcf6c508044612844a78891d09af06
64 Na40ac805129d4631b2c3b1adb2bbb20b
65 Nee05d069dd6a420a805ff144895f89cc
66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007952018
67 https://doi.org/10.1007/s10549-012-2404-y
68 schema:sdDatePublished 2019-04-10T19:08
69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
70 schema:sdPublisher N3a0df7ddefe7470f8f470544169e31c2
71 schema:url http://link.springer.com/10.1007%2Fs10549-012-2404-y
72 sgo:license sg:explorer/license/
73 sgo:sdDataset articles
74 rdf:type schema:ScholarlyArticle
75 N022438ac248a41e7ae6dd007429a801f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
76 schema:name Middle Aged
77 rdf:type schema:DefinedTerm
78 N0a30286f30654c79be43aa9fe1f1a822 schema:name pubmed_id
79 schema:value 23292119
80 rdf:type schema:PropertyValue
81 N0d209143d9e1472cab2c85619c9a398f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Female
83 rdf:type schema:DefinedTerm
84 N13f7588521d14dd3adeeaea81c433a3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Risk Factors
86 rdf:type schema:DefinedTerm
87 N17d470e5f08b4b09b8dac79ace159482 rdf:first sg:person.01250560002.28
88 rdf:rest N4cabf09e05064f27ac67011125c24afc
89 N2f85136ac46640a69ef936c7bb69c2d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Humans
91 rdf:type schema:DefinedTerm
92 N3a0df7ddefe7470f8f470544169e31c2 schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 N3dc877203f44419abf09f62c59a64cd6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Diabetes Mellitus
96 rdf:type schema:DefinedTerm
97 N3e4fd855d3394a63983c409e686b4656 schema:name doi
98 schema:value 10.1007/s10549-012-2404-y
99 rdf:type schema:PropertyValue
100 N3e783fce4d86412bb263cbc0a5937d3e schema:issueNumber 3
101 rdf:type schema:PublicationIssue
102 N3f3592b7f66c43d5b151422256f20920 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Biomarkers, Tumor
104 rdf:type schema:DefinedTerm
105 N46dcf6c508044612844a78891d09af06 schema:name readcube_id
106 schema:value 25e1e1675fa0136907d649057df204ac8116b78c11767d8a5281703e0934f79f
107 rdf:type schema:PropertyValue
108 N4cabf09e05064f27ac67011125c24afc rdf:first sg:person.0605031045.15
109 rdf:rest Na2c922c9d27f482bb62e60971f9ea5c9
110 N4dcad98baf8c4842a0fc0bfb6e8829fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Retrospective Studies
112 rdf:type schema:DefinedTerm
113 N62a1259d98084bf495f8fda009822087 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Aged
115 rdf:type schema:DefinedTerm
116 N6464f2b47ffe448a80a213ba8ce7e2d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Prognosis
118 rdf:type schema:DefinedTerm
119 N6f0529cdfc9248c09e8e3d804de31cb2 rdf:first sg:person.01240745050.60
120 rdf:rest rdf:nil
121 N90189190e0ea49d5a0281bcbd25d8803 schema:volumeNumber 137
122 rdf:type schema:PublicationVolume
123 Na0ed53a14fa444139ea62f729ff807f7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Follow-Up Studies
125 rdf:type schema:DefinedTerm
126 Na278e327002b481681f5b9c2b440c1eb rdf:first sg:person.01207031500.94
127 rdf:rest N6f0529cdfc9248c09e8e3d804de31cb2
128 Na2c922c9d27f482bb62e60971f9ea5c9 rdf:first Nb6572a73feda4a17bb7483537f253acd
129 rdf:rest Na278e327002b481681f5b9c2b440c1eb
130 Na40ac805129d4631b2c3b1adb2bbb20b schema:name dimensions_id
131 schema:value pub.1007952018
132 rdf:type schema:PropertyValue
133 Nac0548961219439a951dd953df158f79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Hypoglycemic Agents
135 rdf:type schema:DefinedTerm
136 Naf809d530576456aa161a35bfc69150d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Adult
138 rdf:type schema:DefinedTerm
139 Nb06a664368104841bf116a694c062768 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Breast Neoplasms
141 rdf:type schema:DefinedTerm
142 Nb6572a73feda4a17bb7483537f253acd schema:affiliation https://www.grid.ac/institutes/grid.411918.4
143 schema:familyName Wang
144 schema:givenName Pei
145 rdf:type schema:Person
146 Ndd9d1673122e4941a4293075ffa74231 rdf:first sg:person.01140643410.19
147 rdf:rest N17d470e5f08b4b09b8dac79ace159482
148 Nee05d069dd6a420a805ff144895f89cc schema:name nlm_unique_id
149 schema:value 8111104
150 rdf:type schema:PropertyValue
151 Nefc7f27aa25542b69b41675bfea83572 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Neoplasm Staging
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1092777 schema:issn 0167-6806
161 1573-7217
162 schema:name Breast Cancer Research and Treatment
163 rdf:type schema:Periodical
164 sg:person.01140643410.19 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
165 schema:familyName Hou
166 schema:givenName Guofang
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01140643410.19
168 rdf:type schema:Person
169 sg:person.01207031500.94 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
170 schema:familyName Hao
171 schema:givenName Xiaomeng
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207031500.94
173 rdf:type schema:Person
174 sg:person.01240745050.60 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
175 schema:familyName Zhang
176 schema:givenName Jin
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240745050.60
178 rdf:type schema:Person
179 sg:person.01250560002.28 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
180 schema:familyName Zhang
181 schema:givenName Sheng
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250560002.28
183 rdf:type schema:Person
184 sg:person.0605031045.15 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
185 schema:familyName Zhang
186 schema:givenName Xiaobei
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605031045.15
188 rdf:type schema:Person
189 sg:pub.10.1007/s10549-011-1612-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015281687
190 https://doi.org/10.1007/s10549-011-1612-1
191 rdf:type schema:CreativeWork
192 sg:pub.10.1007/s10549-012-2170-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1022720204
193 https://doi.org/10.1007/s10549-012-2170-x
194 rdf:type schema:CreativeWork
195 sg:pub.10.1007/s10911-008-9097-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041148032
196 https://doi.org/10.1007/s10911-008-9097-1
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/s12032-011-0109-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017161682
199 https://doi.org/10.1007/s12032-011-0109-4
200 rdf:type schema:CreativeWork
201 sg:pub.10.1038/sj.bjc.6603756 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030523104
202 https://doi.org/10.1038/sj.bjc.6603756
203 rdf:type schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1078212999 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1078311517 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1078511031 schema:CreativeWork
207 https://doi.org/10.1001/jama.2008.824 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010395233
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1002/(sici)1096-9896(200004)190:5<537::aid-path577>3.0.co;2-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1048279462
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1002/cncr.26420 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030440807
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1002/cncr.26439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007397922
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1016/j.breast.2008.02.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032864891
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/j.numecd.2009.02.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006412637
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/s0140-6736(10)60706-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126158
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/s0140-6736(11)60679-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010816607
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/s1535-6108(02)00055-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008635409
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1056/nejmoa1010679 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044293745
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1093/annonc/mdr534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011989210
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1111/j.1582-4934.2010.01083.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023042313
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1126/science.1092952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028575709
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1158/0008-5472.can-07-2310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027138181
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1158/1940-6207.capr-08-0081 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036462269
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1200/jco.2008.17.0829 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042903570
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1200/jco.2009.19.6410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044475739
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1200/jco.2011.39.7505 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024154053
242 rdf:type schema:CreativeWork
243 https://doi.org/10.2337/dc08-2175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028017606
244 rdf:type schema:CreativeWork
245 https://doi.org/10.2337/dc11-1313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004387520
246 rdf:type schema:CreativeWork
247 https://doi.org/10.3978/j.issn.2072-1439.2012.10.17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078655931
248 rdf:type schema:CreativeWork
249 https://doi.org/10.3978/j.issn.2223-4292.2011.12.01 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078663857
250 rdf:type schema:CreativeWork
251 https://doi.org/10.4161/cc.8.1.7499 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072299977
252 rdf:type schema:CreativeWork
253 https://doi.org/10.4161/cc.9.1.10407 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072300749
254 rdf:type schema:CreativeWork
255 https://www.grid.ac/institutes/grid.411918.4 schema:alternateName Tianjin Medical University Cancer Institute and Hospital
256 schema:name 3rd Department of Breast Cancer, China Tianjin Breast Cancer Prevention, Treatment and Research Center, Tianjin Medical University Cancer Institute and Hospital, West Beihuanhu Road, 300060, Tianjin, People’s Republic of China
257 Key Laboratory of Breast Cancer Prevention and Therapy of Ministry of Education, Tianjin, People’s Republic of China
258 Key Laboratory of Cancer Prevention and Therapy, Tianjin, People’s Republic of China
259 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...